<DOC>
	<DOCNO>NCT01307527</DOCNO>
	<brief_summary>Brittle Cornea Syndrome Ehlers-Danlos Syndrome ( EDS ) type VI rare collagen-connective tissue disorder predispose affected individual development perforate corneas mild eye trauma even spontaneously . Clinical study evaluate riboflavin-corneal crosslinking find dramatically increase corneal rigidity . Given success safety riboflavin crosslinking , investigator believe increase corneal stability patient affected disseases , prevent perforation . It furthermore possible , riboflavin crosslinking allow corneal transplant successfully perform blind eye already perforate opacified . The purpose study determine whether corneal crosslinking safely perform individual Brittle Cornea Syndrome Ehlers-Danlos Syndrome type VI .</brief_summary>
	<brief_title>Riboflavin Corneal Crosslinking Brittle Cornea Syndrome Ehlers-Danlos Syndrome Type VI</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Corneal Diseases</mesh_term>
	<mesh_term>Ehlers-Danlos Syndrome</mesh_term>
	<mesh_term>Eye Abnormalities</mesh_term>
	<mesh_term>Joint Instability</mesh_term>
	<mesh_term>Skin Abnormalities</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>Adult Patient : 1 . Genetic diagnosis either Brittle Cornea Syndrome EDSVI , 2 . Either : Personal History either spontaneous corneal perforation corneal perforation due minor ocular mechanical trauma Immediate family member history either spontaneous corneal perforation corneal perforation due minor ocular mechanical trauma Any patient deem unable fully cooperate crosslinking procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>